Evolent Health Q1 Adj $0.34 Beats $0.24 Estimate, Sales $639.65M Beat $600.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolent Health (EVH) reported Q1 earnings of $0.34 per share, surpassing the $0.24 estimate, marking a 61.9% increase from last year. Sales reached $639.65M, exceeding the $600.82M estimate, a 49.56% increase from the previous year.
May 09, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolent Health reported a significant beat on both earnings and sales estimates for Q1, with earnings per share at $0.34 and sales at $639.65M.
Evolent Health's earnings and sales beat are likely to positively impact its stock price in the short term. The substantial beat on both fronts indicates strong company performance and could lead to increased investor confidence and demand for EVH shares.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100